Multivalent human-bovine rotavirus vaccine
CA 2336875 C · Owner: Chanock, Robert M. · Inventors: Kapikian, Albert Z.; Hoshino, Yasutaka; Chanock, Robert M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides vaccine compositions for protection against human rotaviral disease without significant reactogenicity. Human x bovine reassortant rotavirus comprising each of the four clinically most important VP7 serotypes of human rotavirus are combined in a multivalent formulation which provides a high degree of infectivity and immunogenicity without producing a transient febrile condition. Methods for producing an immunogenic response without producing a transient febrile condition are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 27, 1999 and granted January 7, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 27, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 27, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.